Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Vaccine maker Juvaris gets $6mm from Series A; adds $6mm

Executive Summary

Juvaris BioTherapeutics (cancer and infectious disease vaccines) raised $6mm from Kleiner Perkins Caufield & Byers Pandemic & Biodefense Fund in the first tranche of its Series A financing. Within the next four months, the company hopes to gross another $6mm to bring the Series A total to $12mm.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies